The Colorectal Cancer Screening Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The size of the global colorectal cancer screening market has seen significant growth recently. The market value was $15.61 billion in 2024 and it is projected to reach $16.6 billion in 2025, growing at a compound annual growth rate (CAGR) of 6.3%.
By 2029, the global colorectal cancer screening market is expected to reach a market size of $21.01 billion, growing at a compound annual growth rate of 6.1%.
Download Your Free Sample of the 2025 Colorectal Cancer Screening Market Report and Uncover Key Trends Now!The key drivers in the colorectal cancer screening market are:
• Shift towards non-invasive screening methods
• Increase in home-based screening tests
• Rising prevalence of obesity
• Adoption of value-based healthcare and growth of public-private partnerships
The colorectal cancer screeningmarket covered in this report is segmented –
1) By Type: Stool-Based, Fecal Immunochemical Test (FIT), Fecal Occult Blood Test (FOBT), Stool Deoxyribonucleic Acid (DNA) Test, Colonoscopy, Other Types
2) By Age Group: Below 50 Years, 50-64 Years, Above 65 Years
3) By End User: Hospitals And Clinics, Clinical Laboratories, Diagnostic Imaging Centers, Other End-Users
The key trends in the colorectal cancer screening market are:
• The transition to non-invasive screening techniques is a prominent emerging trend.
• The rise in home-based screening tests is gaining popularity.
• The application of artificial intelligence in screening and diagnostics is a promising development.
• There is a trend towards expanding screening guidelines to younger populations.
Major companies in the colorectal cancer screening market are:
• F. Hoffmann-La Roche AG
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Medtronic plc
• Siemens Healthineers
• FUJIFILM Holdings Corporation
• GE HealthCare
• Boston Scientific Corporation
• Olympus Corporation
• Hologic Inc.
• bioMérieux SA
• QuidelOrtho Corporation
• Sysmex Corporation
• QIAGEN N.V.
• Exact Sciences Corporation
• Guardant Health Inc.
• Eiken Chemical Co. Ltd.
• HemoCue AB
• Clinical Genomics Inc.
• Polymedco LLC
• Hemosure Inc.
• Geneoscopy Inc.
• Novigenix SA
North America was the largest region in the colorectal cancer screening market in 2024